Job title
Requirements
More infos
QA ANALYST – GcP
Cellaïon SA is currently hiring a QA Analyst – GcP.
Your responsibilities:
– Writing of general quality system procedures to support business objectives and comply with regulatory requirements for clinical, production, logistics, QA and QC activities.
– Review and evaluate production batch and QC files (batch records, certificates of analysis and compliance, etc.) prior to the release of clinical batches.
– Manage and update quality assurance system documents.
-…
More Info? Please, download the Job description!
Manufacturing Technician
Cellaïon SA is currently hiring a Manufacturing Technician
Your responsibilities:
– Cell expansion of human liver cells in aseptic conditions.
– Media preparation for cell culture and formulation
– Record of relevant environmental and manufacturing parameters.
– …
More Info? Please, download the Job description!
Regulatory Affaires Manager
Cellaïon SA is currently hiring a Regulatory Affairs Manager
Your responsibilities:
– Obtain, maintain and update existing regulatory authorizations (such as Clinical Trial Applications (CTA) for Cellaïon’s products
– Communicate and advise the Company on general ICH regulatory requirements in support of Cellaïon’s products (advanced therapy medicinal products (ATMPs))
– Compile and submit, in a timely manner, regulatory documents according to regulatory requirements (such as ODD, PIP, Scientific Advice/Pre-IND packages),
– …
More Info? Please, download the Job description!
Clinical Project Manager
Cellaïon SA is currently hiring a Clinical project Manager
Your responsibilities:
– Manage and provide accountability for day-to-day operational aspects of a clinical trial.
– Maintain in-depth knowledge of protocol, therapeutic area and indication
– Serve as primary contact for operational project-specific issues and study deliverables,
– …
More Info? Please, download the Job description!
Date
Publication title
Link
2022-09
A new article on the Multi-Target Effect of HALPCs in the NASH STAM model has recently been published in Cells Journal. “Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model”. Cells is an international, peer-reviewed, open access journal of cell biology, molecular biology, and biophysics This peer-reviewed publication recognizes HALPCs as part of the most recent advances in liver repair strategies. This article is the first to show the results of the in vitro and in vivo properties of HALPCs.
2019
Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders
